Synopsis
Featuring community-based medical oncologists presenting actual de-identified cases from their practices to a panel of renowned clinical investigators, this case-based series provides clinicians with practical management strategies and perspectives on the challenges of clinical decision-making.
Episodes
-
![Non-Hodgkin Lymphoma — Year in Review Series on Relevant New Datasets and Advances]()
Non-Hodgkin Lymphoma — Year in Review Series on Relevant New Datasets and Advances
05/06/2025 Duration: 59minDr Stephen Ansell from Mayo Clinic in Rochester, Minnesota, and Dr Brian Hill from Cleveland Clinic Taussig Cancer Institute in Ohio summarize major treatment advances over the past year and review relevant ongoing clinical trials for patients with non-Hodgkin lymphoma. CME information and select publications here.
-
![Breast Cancer: Additional Perspectives — Year in Review Series on Relevant New Datasets and Advances]()
Breast Cancer: Additional Perspectives — Year in Review Series on Relevant New Datasets and Advances
04/06/2025 Duration: 01h01minDr Ian Krop from Yale Cancer Center in New Haven, Connecticut, and Dr Sara Tolaney from Dana-Farber Cancer Institute in Boston, Massachusetts, summarize major treatment advances over the past year and review relevant ongoing clinical trials for patients with breast cancer. CME information and select publications here.
-
![Prostate Cancer and AKT Inhibitors — Proceedings from a Session Held During the American Urological Association Annual Meeting]()
Prostate Cancer and AKT Inhibitors — Proceedings from a Session Held During the American Urological Association Annual Meeting
03/06/2025 Duration: 01h22minDr Leonard G Gomella from the Sidney Kimmel Cancer Center in Philadelphia, Pennsylvania, Dr Evan Y Yu from the Fred Hutchinson Cancer Center in Seattle, Washington, and Dr Daniel George from Duke Cancer Institute in Durham, North Carolina, discuss important clinical datasets and patient cases relevant to AKT inhibition in the care of patients with prostate cancer. CME information and select publications here.
-
![Systemic Mastocytosis and Myelofibrosis — Fourth Annual National General Medical Oncology Summit]()
Systemic Mastocytosis and Myelofibrosis — Fourth Annual National General Medical Oncology Summit
02/06/2025 Duration: 47minClinical investigators discuss available data guiding the management of systemic mastocytosis and myelofibrosis. CME information and select publications here.
-
![Hepatocellular Carcinoma — Fourth Annual National General Medical Oncology Summit]()
Hepatocellular Carcinoma — Fourth Annual National General Medical Oncology Summit
01/06/2025 Duration: 51minClinical investigators discuss available data guiding the management of hepatocellular carcinoma. CME information and select publications here.
-
![Multiple Myeloma — Fourth Annual National General Medical Oncology Summit]()
Multiple Myeloma — Fourth Annual National General Medical Oncology Summit
31/05/2025 Duration: 50minClinical investigators discuss available data guiding the management of multiple myeloma. CME information and select publications here.
-
![For Oncology Nurses: Pancreatic Cancer — Proceedings from the 2025 Annual ONS Congress]()
For Oncology Nurses: Pancreatic Cancer — Proceedings from the 2025 Annual ONS Congress
30/05/2025 Duration: 01h33minDrs Farshid Dayyani and Philip A Philip and oncology nursing professionals Caroline Kuhlman and Amanda K Wagner discuss datasets guiding treatment decision-making for patients with metastatic pancreatic cancer and strategies to mitigate and manage treatment-emergent adverse events. NCPD information and select publications here.
-
![Multiple Myeloma — An Interview with Dr Rafael Fonseca on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting]()
Multiple Myeloma — An Interview with Dr Rafael Fonseca on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
28/05/2025 Duration: 50minDr Rafael Fonseca from Mayo Clinic in Phoenix, Arizona, discusses datasets from the 2024 ASH meeting on the management of newly diagnosed and relapsed/refractory multiple myeloma. CME information and select publications here.
-
![5-Minute Journal Club Issue 8 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer]()
5-Minute Journal Club Issue 8 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
27/05/2025 Duration: 13minDr Rinath Jeselsohn from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer. CME information and select publications here.
-
![Gastroesophageal Cancer — Fourth Annual National General Medical Oncology Summit]()
Gastroesophageal Cancer — Fourth Annual National General Medical Oncology Summit
26/05/2025 Duration: 52minClinical investigators discuss available data guiding the management of gastroesophageal cancer. CME information and select publications here.
-
![Chronic Lymphocytic Leukemia — An Interview with Dr Lindsey Roeker on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting]()
Chronic Lymphocytic Leukemia — An Interview with Dr Lindsey Roeker on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
24/05/2025 Duration: 48minDr Lindsey Roeker from Mayo Clinic in Rochester, Minnesota, discusses recent updates on available and novel treatment strategies for chronic lymphocytic leukemia. CME information and select publications here.
-
![Relapsed/Refractory Follicular Lymphoma Part 3 — A Roundtable Discussion on the Selection and Sequencing of Other Novel Therapies]()
Relapsed/Refractory Follicular Lymphoma Part 3 — A Roundtable Discussion on the Selection and Sequencing of Other Novel Therapies
23/05/2025 Duration: 42minDr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, Dr Matthew Matasar from Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Laurie H Sehn from BC Cancer Centre for Lymphoid Cancer in Vancouver discuss recent updates on available and novel treatment strategies for relapsed/refractory follicular lymphoma. CME information and select publications here.
-
![Urothelial Bladder Cancer — Fourth Annual National General Medical Oncology Summit]()
Urothelial Bladder Cancer — Fourth Annual National General Medical Oncology Summit
22/05/2025 Duration: 49minClinical investigators discuss available data guiding the management of urothelial bladder cancer. CME information and select publications here.
-
![Pancreatic Cancer — Fourth Annual National General Medical Oncology Summit]()
Pancreatic Cancer — Fourth Annual National General Medical Oncology Summit
21/05/2025 Duration: 49minClinical investigators discuss available data guiding the management of pancreatic cancer. CME information and select publications here.
-
![Non-Hodgkin Lymphoma — An Interview with Dr Jennifer Crombie on the Use of Bispecific Antibodies]()
Non-Hodgkin Lymphoma — An Interview with Dr Jennifer Crombie on the Use of Bispecific Antibodies
20/05/2025 Duration: 49minDr Jennifer Crombie from the Dana-Farber Cancer Institute in Boston, Massachusetts, reviews available and investigational CD20 x CD3 targeted bispecific antibodies for the treatment of follicular and diffuse large B-cell lymphomas. CME information and select publications here.
-
![5-Minute Journal Club Issue 7 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer]()
5-Minute Journal Club Issue 7 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
19/05/2025 Duration: 17minDr Rinath M Jeselsohn from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer. CME information and select publications here.
-
![Immunotherapy and Nontargeted Approaches for NSCLC — Fourth Annual National General Medical Oncology Summit]()
Immunotherapy and Nontargeted Approaches for NSCLC — Fourth Annual National General Medical Oncology Summit
18/05/2025 Duration: 50minClinical investigators discuss available data guiding the management of non-small cell lung cancer with immunotherapy and other nontargeted approaches. CME information and select publications here.
-
![Colorectal Cancer — Fourth Annual National General Medical Oncology Summit]()
Colorectal Cancer — Fourth Annual National General Medical Oncology Summit
17/05/2025 Duration: 50minClinical investigators discuss available data guiding the management of colorectal cancer. CME information and select publications here.
-
![Relapsed/Refractory Follicular Lymphoma Part 2 — A Roundtable Discussion on the Selection and Sequencing of CAR T-Cell Therapy]()
Relapsed/Refractory Follicular Lymphoma Part 2 — A Roundtable Discussion on the Selection and Sequencing of CAR T-Cell Therapy
16/05/2025 Duration: 37minDr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, Dr Matthew Matasar from Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Laurie H Sehn from BC Cancer Centre for Lymphoid Cancer in Vancouver discuss recent updates on available and novel treatment strategies for relapsed/refractory follicular lymphoma. CME information and select publications here.
-
![Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances]()
Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances
14/05/2025 Duration: 01h00sDr Emmanuel S Antonarakis from the University of Minnesota in Minneapolis and Professor Karim Fizazi from the Institut Gustave Roussy in Villejuif, France, provide their perspectives on relevant new clinical data in prostate cancer and discuss their application to the care of patients. CME information and select publications here.
